Fairpointe Capital’s Xylem XYL Stock Holding History

Fairpointe Capital’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,910,098	Closed	-$143M	–	84
2015 Q4	$143M	Sell	3,910,098 -313,001	-7%	-$11.3M	2.58%	17
2015 Q3	$139M	Sell	4,223,099 -69,955	-2%	-$2.35M	2.36%	19
2015 Q2	$159M	Sell	4,293,054 -295,841	-6%	-$10.8M	2.22%	19
2015 Q1	$161M	Sell	4,588,895 -6,869	-0.1%	-$242K	2.12%	25
2014 Q4	$175M	Sell	4,595,764 -79,288	-2%	-$2.9M	2.3%	23
2014 Q3	$166M	Sell	4,675,052 -135,457	-3%	-$5.03M	2.22%	20
2014 Q2	$188M	Sell	4,810,509 -315,256	-6%	-$11.8M	2.51%	15
2014 Q1	$187M	Sell	5,125,765 -769,191	-13%	-$28M	2.54%	13
2013 Q4	$204M	Sell	5,894,956 -321,746	-5%	-$10.3M	2.97%	6
2013 Q3	$174M	Buy	+6,216,702	New	+$166M	2.92%	9

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fairpointe Capital's XYL Position: Q1 2016 in Review

Fairpointe Capital sold out of Xylem (XYL) in Q1 2016, closing a stake of 3,910,098 shares — an estimated $143M sold.

Fairpointe Capital first reported a position in XYL in Q3 2013 and held it in 10 quarters. The position peaked at $204M in Q4 2013. 498 funds tracked by Wall St. Rank hold XYL as of Q1 2016.

Fairpointe Capital reported no remaining Xylem position as of Q1 2016 after selling out during the quarter.
Fairpointe Capital sold 3,910,098 Xylem shares in Q1 2016, an estimated $143M.
Fairpointe Capital first reported a position in Xylem in Q3 2013 and held it in 10 quarters.
Fairpointe Capital's Xylem position peaked at $204M in Q4 2013.
498 funds tracked by Wall St. Rank held Xylem as of Q1 2016.

Based on Fairpointe Capital's 13F filing for Q1 2016, filed 13 May 2016.